Cellectis S.A.
CLLS
$1.26
$0.0352.87%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10,351.61% | 4,428.65% | 3,157.55% | -98.23% | -11.43% |
| Total Other Revenue | 24.31% | -20.90% | -42.40% | 31.51% | -12.62% |
| Total Revenue | 997.99% | 374.91% | 82.58% | -88.51% | -12.51% |
| Cost of Revenue | -- | -- | -- | -75.83% | -- |
| Gross Profit | 997.99% | 374.91% | 82.58% | -89.04% | 8.73% |
| SG&A Expenses | 60.12% | -1.72% | 2.82% | 175.25% | -34.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1,558.33% | -29.92% | -131.53% | 196.70% | -90.40% |
| Total Operating Expenses | 29.16% | 4.26% | 3.41% | 34.53% | -23.67% |
| Operating Income | 47.90% | 27.14% | 8.88% | -403.79% | 24.43% |
| Income Before Tax | -33.03% | 13.59% | 119.33% | -147.28% | 31.98% |
| Income Tax Expenses | -155.66% | -174.81% | -- | -93.10% | -- |
| Earnings from Continuing Operations | -31.88% | 14.98% | 120.27% | -146.47% | 31.57% |
| Earnings from Discontinued Operations | -- | -- | -- | 784.00% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | 14.16% | -- |
| Net Income | -31.88% | -115.85% | 118.76% | -59.86% | 38.59% |
| EBIT | 47.90% | 27.14% | 8.88% | -403.79% | 24.43% |
| EBITDA | 55.99% | 31.63% | 10.53% | -960.84% | 26.66% |
| EPS Basic | 26.77% | -33.52% | 113.45% | -11.87% | 49.69% |
| Normalized Basic EPS | 51.82% | 27.00% | 116.46% | -63.79% | 3.51% |
| EPS Diluted | 26.77% | -33.52% | 74.34% | -11.74% | 50.08% |
| Normalized Diluted EPS | 51.82% | 27.00% | 111.46% | -63.79% | 3.51% |
| Average Basic Shares Outstanding | 80.08% | 61.65% | 39.57% | 42.89% | 22.05% |
| Average Diluted Shares Outstanding | 80.08% | 61.65% | 100.37% | 42.89% | 22.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
